✦ LIBER ✦

Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis

✍ Scribed by Thompson, Joel P.; Abdolahi, Amir; Noyes, Katia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CL

✍ LD Goldberg; KS Akhras; A AL-Sabbagh; B Hall 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Cost-Effectiveness of Disease-Modifying

✍ Manouchehrinia, Ali; Constantinescu, Cris S. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 186 KB

Update on Disease-Modifying Treatments f

✍ Carrithers, Michael D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 282 KB

ND1 COST-EFFECTIVENESS OF DISEASE-MODIFY

✍ K Noyes; A Bajorska; AR Chappel; S Schwid; LR Mehta; R Holloway; A Dick 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Cost-Effectiveness of Disease-Modifying

✍ Paul Tappenden; Christopher McCabe; Jim Chilcott; Emma Simpson; Richard Nixon; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

How should we proceed with disease-modif

✍ Peter-Brian Andersson; Emmanuelle Waubant; Donald E Goodkin 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 29 KB